CareCloud to Present at The Microcap Conference 2025
Somerset, NJ, Jan. 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the 'Company') (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025 at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
CareCloud's management team will deliver a corporate presentation highlighting the Company's recent developments, innovative solutions, and strategic growth initiatives. Additionally, the team will participate in one-on-one meetings with institutional and individual investors to explore opportunities and discuss CareCloud's roadmap for continued growth and value creation.
'We are excited to discuss CareCloud's many recent milestones, including the imminent resumption of our Preferred Stock dividends in February 2025, the overwhelming support we received from shareholders in our most recent proxy to increase our authorized common shares, and our strong profitability growth during 2024,' said Stephen Snyder, Co-CEO of CareCloud. 'These achievements, together with our stock performance over the last year, reflect investor confidence in our strategy and execution.'
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from growth-oriented companies. The event provides an unparalleled platform for companies to showcase their value propositions through corporate presentations, expert panels, and networking opportunities.
The 2025 conference highlights include:
Keynote Speakers: Renowned industry leaders, including Jon Ledecky, Co-Owner of the New York Islanders, and Tom Gardner, CEO of Motley Fool, will share their insights on investing and market trends.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover pressing topics, including capital formation, regulatory updates, and equity market trends.
Entertainment Headliner: Comedian and Netflix star Tom Papa will headline an evening performance, adding a touch of entertainment to the event.
Hosted by DealFlow Events, The Microcap Conference is celebrated for combining high-quality financial insights with engaging networking and entertainment experiences. For more information, visit The Microcap Conference.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com.
To listen to video presentations by CareCloud's management team, read recent press releases and view our latest investor presentation, please visit ir.carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'might,' 'will,' 'shall,' 'should,' 'could,' 'intends,' 'expects,' 'plans,' 'goals,' 'projects,' 'anticipates,' 'believes,' 'seeks,' 'estimates,' 'forecasts,' 'predicts,' 'possible,' 'potential,' 'target,' or 'continue' or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled 'Risk Factors' in the Company's filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:Norman RothInterim Chief Financial Officer and Corporate ControllerCareCloud, Inc. nroth@carecloud.com
Investor Contact:Stephen SnyderCo-Chief Executive OfficerCareCloud, Inc.ir@carecloud.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
36 minutes ago
- Business Insider
‘Time to Take a Pause,' Says Investor About Nvidia Stock
Nvidia (NASDAQ:NVDA) stock has roared back to life over the past two months, following a decidedly uncharacteristic drop earlier in the year. Shares have now climbed roughly 50% since hitting a post-Liberation Day low, driven by easing trade tensions, strong AI demand, and another impressive earnings report last month. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter That rebound comes despite several headwinds earlier in the year. The U.S.-China trade spat and fears of a broader pullback in AI-related capital expenditures had weighed heavily on investor sentiment. In particular, a targeted export restriction from the Trump administration on Nvidia's H20 GPUs resulted in a $4.5 billion hit during the last quarter. Still, it is hard to argue with Nvidia's stellar performance during Q1 Fiscal 2026, during which the company delivered record revenues of $44 billion, a year-over-year surge of 69%. The all-important data center segment grew at an even faster clip of 73%. While acknowledging the healthy earnings and NVDA's recovering share price, investor Johnny Zhang is not convinced that all the geopolitical hiccups are in the rearview mirror. 'I believe the 2H 2025 could bring more uncertainty, as the lagging effects of Trump's tariff policy and any setbacks on potential deals with China could create new volatility in the market,' explains the investor. Those concerns are not just theoretical. Zhang points to the unresolved H20 issue, stemming from U.S. export restrictions, as a key example. Nvidia is now expected to take an $8 billion inventory write-off as a result, and its margins are likely to decline further on a sequential basis. More broadly, the company has acknowledged it could forfeit access to a $50 billion total addressable market in China if those restrictions remain in place. Moreover, while Zhang believes that Nvidia will be able to navigate any economic slowdowns, the investor thinks there is a high possibility that the impact of the Trump tariffs will be felt during the latter part of the year. Against that backdrop, Zhang emphasizes that the recent rally in Nvidia's stock may not be sustainable without renewed visibility. He notes that further upside will hinge largely on AI spending trends in 2026, an outlook he calls 'highly uncertain.' In short, while Nvidia's fundamentals remain strong, its near-term growth path is anything but guaranteed. 'Chasing the stock's rally from here seems less compelling to me,' concludes Zhang, who gives NVDA a Hold (i.e. Neutral) rating. (To watch Zhang's track record, click here) Wall Street has a decidedly rosier view of NVDA. With 35 Buy, 4 Hold, and 1 Sell recommendations, NVDA continues to enjoy a Strong Buy consensus rating. Its 12-month average price target of $172.36 implies an upside north of 20%. (See )
Business Insider
an hour ago
- Business Insider
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR) Receives a Buy from Bell Potter
In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR – Research Report), with a price target of A$2.25. The company's shares closed last Friday at A$1.17. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Jacobs covers the Healthcare sector, focusing on stocks such as EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh, Trajan Group Holdings Ltd, and Medical Developments International Limited. According to TipRanks, Jacobs has an average return of -21.1% and a 13.58% success rate on recommended stocks. Currently, the analyst consensus on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh is a Strong Buy with an average price target of A$2.80, implying a 140.34% upside from current levels. In a report released on May 29, Wilsons also maintained a Buy rating on the stock with a A$3.00 price target.
Time Business News
2 hours ago
- Time Business News
Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic
In the high-stakes world of Trading Invest Celebrity Italy, where herd mentality often leads to costly mistakes, one investor has built his success on a simple but ruthless principle: When others zig, zag. Corrado Garibaldi—better known in finance circles as Lord Conrad—has carved a reputation as a maverick trader who thrives on going against the grain. His mantra? 'Buy the fear. Sell the euphoria.' The Unconventional Path to Trading Mastery Unlike Wall Street's typical Ivy League-educated financiers, Garibaldi is a self-made trader with no formal finance background. An Italian native, he entered the markets out of necessity, driven by a desire to take control of his financial future. 'I never studied economics or attended business school,' he admits. 'I learned by doing—making mistakes, refining strategies, and realizing that most people lose money because they follow the crowd.' The Contrarian Edge: Why 99.9999% of Traders Are Wrong Garibaldi's core philosophy is rooted in contrarian investing—a strategy that capitalizes on market overreactions. 'When everyone is buying, I'm selling. When panic sets in, I'm buying,' he says. 'The masses are almost always wrong at extremes. That's where the real opportunities lie.' This approach has allowed him to profit from major market swings, whether during the crypto crashes of 2022 or the AI stock frenzy of 2024. Two Sides of the Same Coin: Trader by Day, Investor by Night Garibaldi operates in two distinct modes: As a trader, he's a speed-focused tactician, scalping the Nasdaq and executing swing trades with military precision. As an investor, he's a patient wealth-builder, holding long-term positions in giants like Apple, Microsoft, and Tesla while diversifying into bonds and crypto. His portfolio strategy? 99% long-term holdings, 1% high-octane trading—a balance that maximizes growth while keeping risk in check. The Trader's Mindset: Why Psychology Beats IQ For Garibaldi, trading isn't just about charts—it's about mastering fear and greed. 'Most traders fail because they let emotions drive decisions,' he says. 'The key is to stay mechanical. Follow the plan, not the panic.' He enforces strict rules: ✔ Never risk more than 1% on a single trade ✔ Always use stop-losses ✔ Ignore hype—trade the data, not the narrative 2025 and Beyond: Adapt or Die In an era of AI-driven markets and geopolitical volatility, Garibaldi remains agile—constantly refining strategies and engaging with traders worldwide via social media. 'Markets change. If you're not learning, you're losing,' he warns. Final Word: The Slow Road to Trading Success For aspiring traders, Garibaldi's advice is refreshingly honest: 'This isn't a get-rich-quick game. Consistency beats luck. Small, smart gains compound over time—that's how real wealth is built.' Want to see his strategies in action? Visit Trading Invest Celebrity Italy. TIME BUSINESS NEWS
